BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26310077)

  • 1. High Drug Payload 10-Hydroxycamptothecin Nanosuspensions Stabilized by Cholesterol-PEG: In Vitro and In Vivo Investigation.
    Yang L; Jiang J; Hong J; Di J; Liao Y; Kuang H; Wang X
    J Biomed Nanotechnol; 2015 Apr; 11(4):711-21. PubMed ID: 26310077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
    Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
    Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
    Han M; Liu X; Guo Y; Wang Y; Wang X
    Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation.
    Hong J; Liu Y; Xiao Y; Yang X; Su W; Zhang M; Liao Y; Kuang H; Wang X
    Drug Deliv; 2017 Nov; 24(1):109-120. PubMed ID: 28155567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions.
    Zhao YX; Hua HY; Chang M; Liu WJ; Zhao Y; Liu HM
    Int J Pharm; 2010 Jun; 392(1-2):64-71. PubMed ID: 20302926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
    Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
    Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
    Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of hydroxycamptothecin nanosuspensions in rats.
    Wang L; Hua HY; Liu WJ; Zhao YX; Zhang ZZ
    Pharmazie; 2011 Jul; 66(7):547-8. PubMed ID: 21812333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
    Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
    Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system.
    Han M; Yu X; Guo Y; Wang Y; Kuang H; Wang X
    Colloids Surf B Biointerfaces; 2014 Apr; 116():114-20. PubMed ID: 24448177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annonaceous acetogenins (ACGs) nanosuspensions based on a self-assembly stabilizer and the significantly improved anti-tumor efficacy.
    Hong J; Li Y; Xiao Y; Li Y; Guo Y; Kuang H; Wang X
    Colloids Surf B Biointerfaces; 2016 Sep; 145():319-327. PubMed ID: 27209384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nanoparticulate drug-delivery system for 20(S)-protopanaxadiol: formulation, characterization, increased oral bioavailability and anti-tumor efficacy.
    Han M; Ma L; Yu X; Li Z; Guo Y; Wang X
    Drug Deliv; 2016 Sep; 23(7):2410-2418. PubMed ID: 25564965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
    Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
    Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
    Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice.
    Zhang L; Yang M; Wang Q; Li Y; Guo R; Jiang X; Yang C; Liu B
    J Control Release; 2007 Jun; 119(2):153-62. PubMed ID: 17400320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo.
    Pang X; Wang T; Jiang D; Mu W; Zhang B; Zhang N
    Int J Nanomedicine; 2019; 14():2543-2555. PubMed ID: 31114190
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions.
    Wang L; Liu Y; Zhao J; Li C; Zhou Y; Du J; Wang Y
    Colloids Surf B Biointerfaces; 2017 Dec; 160():462-472. PubMed ID: 28988124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice.
    Li H; Li Y; Ao H; Bi D; Han M; Guo Y; Wang X
    Drug Deliv; 2018 Nov; 25(1):880-887. PubMed ID: 29608108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo imaging in tumor-bearing animals and pharmacokinetics of PEGylated liposomes modified with RGD cyclopeptide].
    Tu LX; Xu YH; Tang CY; Deng LH; Wu CB
    Yao Xue Xue Bao; 2012 May; 47(5):646-51. PubMed ID: 22812011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.